Stock Scorecard



Stock Summary for ATAI Life Sciences N.V. (ATAI) - $3.82 as of 2/20/2026 2:38:42 PM EST

Total Score

7 out of 30

Safety Score

-5 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ATAI

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ATAI

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ATAI

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ATAI

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ATAI (-5 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -40

Latest News for for ATAI

Compass Pathways stock slip as psilocybin depression trial falls short of expectations 2/20/2026 10:07:00 PM
AtaiBeckley To Host Virtual Investor Day on March 6, 2026 2/20/2026 12:52:00 PM
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer 2/19/2026 2:27:00 PM
AtaiBeckley To Participate in Upcoming Investor Conferences 2/18/2026 2:58:00 AM
H.C. Wainwright Remains Bullish on AtaiBeckley Inc. (ATAI) 1/29/2026 7:01:00 PM
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 1/19/2026 11:28:00 AM
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation 1/18/2026 12:30:00 PM
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation 1/18/2026 12:30:00 PM
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… 1/16/2026 2:58:00 PM
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation 1/16/2026 12:58:00 PM

Financial Details for ATAI

Company Overview

Ticker ATAI
Company Name ATAI Life Sciences N.V.
Country USA
Description ATA Creativity Global provides educational services to students in China. The company is headquartered in Beijing, China.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 9/30/2025
Next Earnings Date 3/16/2026

Stock Price History

Last Day Price 3.82
Price 4 Years Ago 2.66
Last Day Price Updated 2/20/2026 2:38:42 PM EST
Last Day Volume 4,521,286
Average Daily Volume 3,866,899
52-Week High 6.75
52-Week Low 1.15
Last Price to 52 Week Low 232.17%

Valuation Measures

Trailing PE N/A
Industry PE 18.63
Sector PE 148.47
5-Year Average PE -3.47
Free Cash Flow Ratio 47.75
Industry Free Cash Flow Ratio 12.36
Sector Free Cash Flow Ratio 31.12
Current Ratio Most Recent Quarter 7.90
Total Cash Per Share 0.08
Book Value Per Share Most Recent Quarter 0.66
Price to Book Ratio 8.16
Industry Price to Book Ratio 3.36
Sector Price to Book Ratio 33.63
Price to Sales Ratio Twelve Trailing Months 459.73
Industry Price to Sales Ratio Twelve Trailing Months 47.64
Sector Price to Sales Ratio Twelve Trailing Months 23.44
Analyst Buy Ratings 11
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 363,215,000
Market Capitalization 1,387,481,300
Institutional Ownership 32.08%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -96.80%
Annual Earnings Growth -271.09%
Reported EPS 12 Trailing Months -0.83
Reported EPS Past Year -0.57
Reported EPS Prior Year -0.93
Net Income Twelve Trailing Months -154,192,000
Net Income Past Year -149,269,000
Net Income Prior Year -40,224,000
Quarterly Revenue Growth YOY 1,773.00%
5-Year Revenue Growth -75.27%
Operating Margin Twelve Trailing Months -3,797.00%

Balance Sheet

Total Cash Most Recent Quarter 30,402,000
Total Cash Past Year 17,505,000
Total Cash Prior Year 45,034,000
Net Cash Position Most Recent Quarter 21,102,000
Net Cash Position Past Year 3,372,000
Long Term Debt Past Year 14,133,000
Long Term Debt Prior Year 17,877,000
Total Debt Most Recent Quarter 9,300,000
Equity to Debt Ratio Past Year 0.89
Equity to Debt Ratio Most Recent Quarter 0.94
Total Stockholder Equity Past Year 116,297,000
Total Stockholder Equity Prior Year 242,962,000
Total Stockholder Equity Most Recent Quarter 159,751,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -90,338,000
Free Cash Flow Per Share Twelve Trailing Months -0.25
Free Cash Flow Past Year -82,532,000
Free Cash Flow Prior Year -84,708,000

Options

Put/Call Ratio 0.04
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 2.71
20-Day Bollinger Middle Band 4.31
20-Day Bollinger Upper Band 5.91
Beta 1.62
RSI 53.26
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 2/20/2026 5:44:39 PM EST